NRP1 and triple-negative breast carcinoma: Tri-functionalized nanoparticles containing NRP-1 peptides, doxorubicin (DOX) and near-infrared cyanine dye (Cy7) have also been explored in in vitro and in vivo triple-negative breast cancer models [19].